TRDA Entrada Therapeutics, Inc.

$7.06 +3.98%

Healthcare · Pharmaceutical Preparations

Entrada Therapeutics, Inc. (TRDA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $274 million. Shares last traded at $7.06, 57.0% below their 52-week high. Over the past year the stock is down 2.6%. Net profit margin is -565.5%, below the peer median of -0.1%. Revenue declined 87.9% year over year.

Market Cap

$274M

Shares Out

38.8M

EPS (TTM)

$-5.37

P/E Ratio

—

P/S Ratio

10.78

P/B Ratio

1.01

Dividend / Share

—

Dividend Yield

—

52-Week High

$16.43

52-Week Low

$4.93

Volume

14,227

Avg Vol (3m)

18,968.857

Performance

+11.80%

+24.73%

-40.62%

-38.02%

YTD

-29.68%

-2.62%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

46.71

SMA (50)

$9.48

SMA (200)

$9.44

Price vs SMA50

-25.50%

Price vs SMA200

-25.22%

ATR (14)

$0.64

Financials

Revenue

$25M

Net Income

$-144M

Gross Margin

—

Operating Margin

-621.1%

Net Margin

-565.5%

Return on Equity

-53.1%

Return on Assets

-42.8%

Current Ratio

13.90

Debt / Equity

0.24

Revenue Growth (YoY)

-87.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.95	2026-05-07
FY 2025	$-3.47	2026-02-26
Q3 2025	$-2.53	2025-11-06
Q2 2025	$-1.47	2025-08-06
Q1 2026	$-0.42	2026-05-07
FY 2025	$1.68	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

TRDA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

10.78 / 3.54 med

+205% premium

Net margin vs peers

-565.5% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.